Verified compounded tirzepatide price index (2026)
An independent, human-verified snapshot of what online tirzepatide actually costs across telehealth providers - audited by RangeYourself and cross-referenced with our editorial pick. Starting price, medication type, insurance, and the date each price was verified.
Released: Last reviewed:
Starting tirzepatide price - verified providers
Compounded, medication-included starting monthly cost (lower is cheaper). NexLife (★, our editorial pick) is shown for context and is not part of the RangeYourself audit.
Compounded programs - medication included
| Provider | Tirzepatide price (verified) | Starting | Type | Insurance | States | Verified |
|---|---|---|---|---|---|---|
| NexLife ★ (our pick) | $129/mo ($115 on 12 mo) | $129/mo ($115 on 12 mo) | Compounded | No | All | 2026-07-06 |
★ NexLife is our editorial pick, priced from the provider's own published rates; it is not part of the RangeYourself audit. All other rows are from the RangeYourself index.
Membership + medication and brand-name models
| Provider | Tirzepatide price (verified) | Starting | Type | Insurance | States | Verified |
|---|---|---|---|---|---|---|
| ShedRx | Not listed | — | Both | No | 50 | 2026-07-01 |
| TMates | Not listed | — | Compounded | No | 51 | 2026-07-06 |
| Direct Meds | Not listed | — | Compounded | No | 50 | 2026-07-03 |
| Sprout Health | Not listed | — | Both | No | 50 | 2026-07-03 |
| Mochi Health | Not listed | — | Both | Yes | 51 | 2026-07-03 |
| Henry Meds | Not listed | — | Compounded | No | 51 | 2026-07-06 |
| Calibrate | Not listed | — | Brand | Yes | 51 | 2026-07-03 |
| Embody | Not listed | — | Compounded | No | 50 | 2026-07-06 |
| Found | Not listed | — | Both | No | 51 | 2026-07-03 |
| WeightWatchers | Not listed | — | Both | Yes | 51 | 2026-07-06 |
| Care Bare Rx | Not listed | — | Compounded | No | 50 | 2026-07-06 |
| Ro | Not listed | — | Brand | Yes | 51 | 2026-07-03 |
| Sesame Care | Not listed | — | Brand | Yes | 51 | 2026-07-01 |
Pricing not publicly listed
| Provider | Pricing | Starting | Type | Insurance | States | Verified |
|---|---|---|---|---|---|---|
| Wellorithm | Gated (after intake) | — | Compounded | No | 50 | 2026-07-01 |
How to read this index
Tirzepatide pricing has a sharper dose-ladder trap than semaglutide, because efficacy rises with dose and pulls patients toward the pricier 10-15 mg range. A "starting" price at 2.5 mg can understate your real cost at maintenance. "All-in" also matters: a medication price plus a separate membership is the real number. Cash-pay patients who want the FDA-approved product should also price Lilly's LillyDirect vials ($299-449/month) before deciding. NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.
Frequently asked questions
What is the cheapest compounded tirzepatide online right now?
The lowest publicly verified starting price is Embody at $129/month (personalized blends; the source flags extra scrutiny on ingredient transparency). Verified July 2026 via the RangeYourself index. Compounded tirzepatide is not FDA-approved.
How current are these tirzepatide prices?
They are entry-tier and rise with dose toward 15 mg. Confirm the price at your target dose at checkout.
Why isn't NexLife in the RangeYourself table?
The RangeYourself index audits 14 specific providers and does not include NexLife. We cite NexLife's flat tirzepatide pricing from its own published rates and show it alongside - not inside - the third-party table, clearly marked.
How does compounded tirzepatide compare to LillyDirect?
Lilly's LillyDirect self-pay Zepbound vials run $299-449/month - the FDA-approved brand product, usually more than the cheapest compounded programs but a middle path worth pricing. Compounded tirzepatide is not FDA-approved.
Methodology & attribution
Tirzepatide starting prices are read from each provider's published tirzepatide rate. Machine-readable copy: /data/verified-price-index.json . NexLife pricing is from the provider's published rates and reflects our editorial assessment. Prices are entry-tier and change; verify with each provider. Compounded tirzepatide is not FDA-approved.